Guardant Health Inc (NASDAQ:GH) crossed MACD Bullish signal line on Friday, June 26, 2020

0
111

Bullish Guardant Health Inc NASDAQ:GH Grade : D stock signal line crossed on Friday, June 26, 2020. on Thursday 11th June’s trading session, with a change of 1.89% per share while daily volume of 853,499 changed hands which is surge of 0.78%

Guardant Health Inc NASDAQ:GH Grade : D stock GH closed up 1.89 percent on Thursday, June 25, 2020, on 78 percent of normal volume.

Earning Guardant Health Inc NASDAQ:GH

Guardant Health last announced its quarterly earnings results on May 7th, 2020. The reported ($0.29) earnings per share for the quarter, beating the consensus estimate of ($0.39) by $0.10. The company had revenue of $67.50 million for the quarter, compared to the consensus estimate of $55.45 million. Its revenue was up 83.9% compared to the same quarter last year. Guardant Health has generated ($0.84) earnings per share over the last year. Guardant Health has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, August 4th, 2020 based off prior year’s report dates.

About Guardant Health Inc NASDAQ:GH

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.

Grade : D